Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets.
about
Modeling HIV/AIDS drug price determinants in Brazil: is generic competition a myth?Global financing and long-term technical assistance for multidrug-resistant tuberculosis: scaling up access to treatmentStrategies for price reduction of HIV medicines under a monopoly situation in Brazil.The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children.Projected savings through public health voluntary licences of HIV drugs negotiated by the Medicines Patent Pool (MPP).A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countriesDriving a decade of change: HIV/AIDS, patents and access to medicines for all.Analysis of prices paid by low-income countries - how price sensitive is government demand for medicines?A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countriesPEPFAR Transitions to Country Ownership: Review of Past Donor Transitions and Application of Lessons Learned to the Eastern Caribbean.Human Resources for Treating HIV/AIDS: Are the Preventive Effects of Antiretroviral Treatment a Game Changer?Assessing the population health impact of market interventions to improve access to antiretroviral treatment.Trends in medicines procurement by the Brazilian federal government from 2006 to 2013.Understanding health systems, health economies and globalization: the need for social science perspectives.Current strategies for improving access and adherence to antiretroviral therapies in resource-limited settings.The market dynamics of generic medicines in the private sector of 19 low and middle income countries between 2001 and 2011: a descriptive time series analysisAffordability of adult HIV/AIDS treatment in developing countries: modelling price determinants for a better insight of the market functioningCan voluntary pooled procurement reduce the price of antiretroviral drugs? a case study of Efavirenz.Using evidence to drive action: a "revolution in accountability" to implement quality care for better maternal and newborn health in Africa.A quiet revolution in global public health: The World Health Organization's Prequalification of Medicines Programme.Legal and policy foundations for global generic competition: Promoting affordable drug pricing in developing societies.
P2860
Q28476569-9BA0A117-B23D-4FC4-859B-737A4E068500Q28543392-CAC18669-FFD4-4332-BCA9-7569B3BA60C2Q30386525-DE4A4E0F-CDF0-4ED7-BD81-AE0D40BB4EE3Q33720016-29965F88-9E33-4F9A-9235-5C2C3209EAECQ33727955-11826125-AA44-4F1D-874E-06BDA0903558Q34152158-13FDD1DE-6436-4B5D-9CF1-2706ECDA94B9Q34808796-FD890ADA-6050-4D94-A38F-6D1E0E02F75DQ34874132-0BD320F2-DE6B-4F82-801F-1FF6C4BD3012Q35545912-B73A0E5E-4A28-4AEF-97D7-4A5999CB5504Q35767810-D5D6CE5F-71E9-4A86-8251-8302E3D062A2Q36157634-AC721DAD-1972-40F5-B394-F8EEAC596A72Q36201249-B077C006-C663-457C-8D69-30DCFC768F7FQ36339862-AAF05D18-21D3-488E-90DE-A0A11690F060Q36529595-C5FD34B5-2449-4DB3-93A4-94D3478A8A1CQ36530478-67950993-D19D-4E90-8926-0064F03B4B4CQ37207470-25D183B7-3B32-4540-8EE5-88BD5AFE8FE0Q37355309-8894D486-A070-4A90-BD36-B2192F46DE1EQ39040089-4E2DD3B5-F5CE-4BB9-99F3-BD49C57A4A22Q39086873-C9F4FFBE-91FC-4C67-8DAE-44D942F04B90Q43935710-636983E6-4B3D-48AC-B604-40A0D042FE2DQ49152817-754D8242-C8E4-48C0-A137-24C0409522B5
P2860
Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Intervening in global markets ...... iretroviral medicines markets.
@ast
Intervening in global markets ...... iretroviral medicines markets.
@en
type
label
Intervening in global markets ...... iretroviral medicines markets.
@ast
Intervening in global markets ...... iretroviral medicines markets.
@en
prefLabel
Intervening in global markets ...... iretroviral medicines markets.
@ast
Intervening in global markets ...... iretroviral medicines markets.
@en
P2093
P2860
P356
P1476
Intervening in global markets ...... iretroviral medicines markets.
@en
P2093
Ellen Diedrichsen
Jenny Hochstadt
Lyne Soucy
Margaret Kyle
Suerie Moon
P2860
P2888
P356
10.1186/1744-8603-6-9
P577
2010-05-25T00:00:00Z
P5875
P6179
1051974373